Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 10Colorectal Neoplasms 8Postoperative Complications 2Anastomotic Leak 2Transfusion Reaction 1Sarcopenia 1Peritoneal Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Metabolomics 1Intestinal Perforation 1Ileus 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis 1Cholecystolithiasis 1Carcinoma, Hepatocellular 1Appendiceal Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Colectomy × Clear all
NCT03432806 2025-12-02

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Memorial Sloan Kettering Cancer Center

Active not recruiting
51 enrolled
Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡